60 Assessing hyaluronidase-facilitated subcutaneous immunoglobulin 20% (fSCIG 20%) pharmacokinetics, safety and tolerability in primary immunodeficiency diseases: phase 2/3 study design
Titel:
60 Assessing hyaluronidase-facilitated subcutaneous immunoglobulin 20% (fSCIG 20%) pharmacokinetics, safety and tolerability in primary immunodeficiency diseases: phase 2/3 study design
Auteur:
LWasserman, Richard Leavis, Helen Nagy, Andras Carrasco, Paz Anderson-Smits, Colin McCoy, Barbara Bauer, Alexander Chu, Liang-Hui Freedman, Immanuel Li, Zhaoyang